Crossref journal-article
American Association for Cancer Research (AACR)
Cancer Research (1086)
Abstract

Abstract Lysyl oxidase (LOX) and HRAS-like suppressor (HRASLS) are silenced in human gastric cancers and are reported to have growth-suppressive activities in ras-transformed mouse/rat fibroblasts. Here, we analyzed whether or not LOX and HRASLS are tumor suppressor genes in human gastric cancers. Loss of heterozygosity and promoter methylation of LOX were detected in 33% (9 of 27) and 27% (26 of 96) of gastric cancers, respectively. Biallelic methylation and loss of heterozygosity with promoter methylation were also demonstrated in gastric cancers. Silencing of LOX was also observed in colon, lung, and ovarian cancer cell lines. As for mutations, only one possible somatic mutation was found by analysis of 96 gastric cancer samples and 58 gastric and other cancer cell lines. When LOX was introduced into a gastric cancer cell line, MKN28, in which LOX and HRASLS were silenced, it reduced the number of anchorage-dependent colonies to 57 to 61%, and the number of anchorage-independent colonies to 11 to 23%. Sizes of tumors formed in nude mice were reduced to 19 to 26%. Growth suppression in soft agar assay was also observed in another gastric cancer cell line, KATOIII. On the other hand, neither loss of heterozygosity nor a somatic mutation was detected in HRASLS, and its introduction into MKN28 did not suppress the growth in vitro or in vivo. These data showed that LOX is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in gastric cancers, and possibly also in other cancers.

Bibliography

Kaneda, A., Wakazono, K., Tsukamoto, T., Watanabe, N., Yagi, Y., Tatematsu, M., Kaminishi, M., Sugimura, T., & Ushijima, T. (2004). Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers. Cancer Research, 64(18), 6410–6415.

Authors 9
  1. Atsushi Kaneda (first)
  2. Kuniko Wakazono (additional)
  3. Tetsuya Tsukamoto (additional)
  4. Naoko Watanabe (additional)
  5. Yukiko Yagi (additional)
  6. Masae Tatematsu (additional)
  7. Michio Kaminishi (additional)
  8. Takashi Sugimura (additional)
  9. Toshikazu Ushijima (additional)
References 43 Referenced 134
  1. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet, 2002; 3: 415-28, (10.1038/nrg816)
  2. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet, 2000; 16: 168-74, (10.1016/S0168-9525(99)01971-X)
  3. Feinberg AP. Cancer epigenetics takes center stage. Proc Natl Acad Sci USA, 2001; 98: 392-4, (10.1073/pnas.98.2.392)
  4. Ushijima T, Morimura K, Hosoya Y, et al Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. Proc Natl Acad Sci USA, 1997; 94: 2284-9, (10.1073/pnas.94.6.2284)
  5. Kaneda A, Takai D, Kaminishi M, Okochi E, Ushijima T. Methylation-sensitive representational difference analysis and its application to cancer research. Ann N Y Acad Sci, 2003; 983: 131-41, (10.1111/j.1749-6632.2003.tb05968.x)
  6. Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science (Wash DC), 1993; 259: 946-51, (10.1126/science.8438152)
  7. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 1999; 80: 827-41, (10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P)
  8. Kaneda A, Kaminishi M, Yanagihara K, Sugimura T, Ushijima T. Identification of silencing of nine genes in human gastric cancers. Cancer Res, 2002; 62: 6645-50,
  9. Contente S, Kenyon K, Rimoldi D, Friedman RM. Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science (Wash DC), 1990; 249: 796-8, (10.1126/science.1697103)
  10. Giampuzzi M, Botti G, Cilli M, et al Down-regulation of lysyl oxidase-induced tumorigenic transformation in NRK-49F cells characterized by constitutive activation of ras proto-oncogene. J Mol Biol, 2001; 276: 29226-32, (10.1074/jbc.M101695200)
  11. Akiyama H, Hiraki Y, Noda M, Shigeno C, Ito H, Nakamura T. Molecular cloning and biological activity of a novel Ha-Ras suppressor gene predominantly expressed in skeletal muscle, heart, brain, and bone marrow by differential display using clonal mouse EC cells, ATDC5. J Mol Biol, 1999; 274: 32192-7, (10.1074/jbc.274.45.32192)
  12. Ito H, Akiyama H, Shigeno C, Nakamura T. Isolation, characterization, and chromosome mapping of a human A-C1 Ha-Ras suppressor gene (HRASLS). Cytogenet Cell Genet, 2001; 93: 36-9, (10.1159/000056944)
  13. Kirschmann DA, Seftor EA, Fong SF, et al A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res, 2002; 62: 4478-83,
  14. Ochiai A, Yasui W, Tahara E. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res, 1985; 76: 1064-71,
  15. Tsao SW, Mok SC, Fey EG, et al Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res, 1995; 218: 499-507, (10.1006/excr.1995.1184)
  16. Liu N, Furukawa T, Kobari M, Tsao MS. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Am J Pathol., 1998; 153: 263-9, (10.1016/S0002-9440(10)65567-8)
  17. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA, 1989; 86: 2766-70, (10.1073/pnas.86.8.2766)
  18. Ushijima T, Hosoya Y, Suzuki T, Sofuni T, Sugimura T, Nagao M. A rapid method for detection of mutations in the lacI gene using PCR-single strand conformation polymorphism analysis: demonstration of its high sensitivity. Mutat Res, 1995; 334: 283-92, (10.1016/0165-1161(95)90065-9)
  19. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res, 1994; 22: 2990-7, (10.1093/nar/22.15.2990)
  20. Rein T, Zorbas H, DePamphilis ML. Active mammalian replication origins are associated with a high-density cluster of mCpG dinucleotides. Mol Cell Biol, 1997; 17: 416-26, (10.1128/MCB.17.1.416)
  21. Kaneda A, Tsukamoto T, Takamura-Enya T, et al Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci, 2004; 95: 58-64, (10.1111/j.1349-7006.2004.tb03171.x)
  22. Hamalainen ER, Kemppainen R, Pihlajaniemi T, Kivirikko KI. Structure of the human lysyl oxidase gene. Genomics, 1993; 17: 544-8, (10.1006/geno.1993.1369)
  23. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Danenberg PV, Laird PW. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res, 1999; 59: 2302-6,
  24. Csiszar K, Fong SF, Ujfalusi A, et al Somatic mutations of the lysyl oxidase gene on chromosome 5q23.1 in colorectal tumors. Int J Cancer, 2002; 97: 636-42, (10.1002/ijc.10035)
  25. Hamalainen ER, Jones TA, Sheer D, Taskinen K, Pihlajaniemi T, Kivirikko KI. Molecular cloning of human lysyl oxidase and assignment of the gene to chromosome 5q23.3–31.2. Genomics, 1991; 11: 508-16, (10.1016/0888-7543(91)90057-L)
  26. Sano T, Tsujino T, Yoshida K, et al Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res, 1991; 51: 2926-31,
  27. Tamura G, Sakata K, Maesawa C, et al Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res, 1995; 55: 1933-6,
  28. Cho KR, Vogelstein B. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J Cell Biochem Suppl, 1992; 16G: 137-41, (10.1002/jcb.240501124)
  29. Willman CL, Sever CE, Pallavicini MG, et al Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science (Wash DC), 1993; 259: 968-71, (10.1126/science.8438156)
  30. Smith-Mungo LI, Kagan HM. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol, 1998; 16: 387-98, (10.1016/S0945-053X(98)90012-9)
  31. Ren C, Yang G, Timme TL, Wheeler TM, Thompson TC. Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer. Cancer Res, 1998; 58: 1285-90,
  32. Stassar MJ, Devitt G, Brosius M, et al Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer, 2001; 85: 1372-82, (10.1054/bjoc.2001.2074)
  33. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol, 1996; 16: 859-67, (10.1128/MCB.16.3.859)
  34. Li W, Nellaiappan K, Strassmaier T, Graham L, Thomas KM, Kagan HM. Localization and activity of lysyl oxidase within nuclei of fibrogenic cells. Proc Natl Acad Sci USA, 1997; 94: 12817-22, (10.1073/pnas.94.24.12817)
  35. Nellaiappan K, Risitano A, Liu G, Nicklas G, Kagan HM. Fully processed lysyl oxidase catalyst translocates from the extracellular space into nuclei of aortic smooth-muscle cells. J Cell Biochem, 2000; 79: 576-82, (10.1002/1097-4644(20001215)79:4<576::AID-JCB60>3.0.CO;2-A)
  36. Giampuzzi M, Oleggini R, Di Donato A. Demonstration of in vitro interaction between tumor suppressor lysyl oxidase and histones H1 and H2: definition of the regions involved. Biochim Biophys Acta, 2003; 1647: 245-51, (10.1016/S1570-9639(03)00059-1)
  37. Jeay S, Pianetti S, Kagan HM, Sonenshein GE. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kB. Mol Cell Biol, 2003; 23: 2251-63, (10.1128/MCB.23.7.2251-2263.2003)
  38. Nanus DM, Kelsen DP, Mentle IR, Altorki N, Albino AP. Infrequent point mutations of ras oncogenes in gastric cancers. Gastroenterology, 1990; 98: 955-60, (10.1016/0016-5085(90)90019-W)
  39. Maesawa C, Tamura G, Suzuki Y, et al The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma [see comments]. J Pathol, 1995; 176: 249-58, (10.1002/path.1711760307)
  40. Krzyzosiak WJ, Shindo-Okada N, Teshima H, Nakajima K, Nishimura S. Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine. Proc Natl Acad Sci USA, 1992; 89: 4879-83, (10.1073/pnas.89.11.4879)
  41. Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene, 2001; 20: 1287-99, (10.1038/sj.onc.1204257)
  42. Yoshikawa H, Matsubara K, Qian GS, et al SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet, 2001; 28: 29-35, (10.1038/ng0501-29)
  43. Hagihara A, Miyamoto K, Furuta J, et al. Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene 2004; in press. (10.1038/sj.onc.1207783)
Dates
Type When
Created 19 years, 11 months ago (Sept. 20, 2005, 6:43 p.m.)
Deposited 2 years, 7 months ago (Jan. 11, 2023, 4 p.m.)
Indexed 1 week, 1 day ago (Aug. 29, 2025, 5:53 a.m.)
Issued 20 years, 11 months ago (Sept. 15, 2004)
Published 20 years, 11 months ago (Sept. 15, 2004)
Published Online 20 years, 11 months ago (Sept. 16, 2004)
Published Print 20 years, 11 months ago (Sept. 15, 2004)
Funders 0

None

@article{Kaneda_2004, title={ Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers}, volume={64}, ISSN={1538-7445}, url={http://dx.doi.org/10.1158/0008-5472.can-04-1543}, DOI={10.1158/0008-5472.can-04-1543}, number={18}, journal={Cancer Research}, publisher={American Association for Cancer Research (AACR)}, author={Kaneda, Atsushi and Wakazono, Kuniko and Tsukamoto, Tetsuya and Watanabe, Naoko and Yagi, Yukiko and Tatematsu, Masae and Kaminishi, Michio and Sugimura, Takashi and Ushijima, Toshikazu}, year={2004}, month=sep, pages={6410–6415} }